ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.700
-0.090 (-3.23%)
Jun 27, 2025, 4:00 PM - Market closed

ImmunityBio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
2,3831,8693,3522,0762,419-
Upgrade
Market Cap Growth
-29.34%-44.23%61.49%-14.18%--
Upgrade
Enterprise Value
3,1442,7593,8822,6762,681-
Upgrade
Last Close Price
2.842.565.025.076.08-
Upgrade
PS Ratio
67.53126.775388.888648.472589.53-
Upgrade
PB Ratio
--3.83-5.72-4.61-9.92-
Upgrade
EV/Sales Ratio
100.70187.096241.2011149.272870.55-
Upgrade
Debt / Equity Ratio
-1.39-1.62-1.51-1.61-2.66-2.33
Upgrade
Asset Turnover
0.090.030.000.000.000.00
Upgrade
Quick Ratio
1.612.784.630.220.861.44
Upgrade
Current Ratio
2.223.365.050.280.911.64
Upgrade
Return on Assets (ROA)
-55.61%-48.48%-52.11%-52.73%-57.48%-72.72%
Upgrade
Return on Capital (ROIC)
-89.75%-71.77%-78.80%-64.47%-70.68%-106.38%
Upgrade
Earnings Yield
-17.17%-22.13%-17.40%-20.07%-14.34%-
Upgrade
FCF Yield
-15.82%-21.30%-11.85%-20.03%-12.73%-
Upgrade
Buyback Yield / Dilution
-30.30%-37.71%-27.19%-2.74%-3.23%-2.93%
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q